Cypros preclinical data

CYPR announced it would plan Phase II trials of the compound in the inherited red cell disorder after reviewing results of preclinical results obtained ex vivo in blood from people with the disease, and from infusion in normal volunteers.

The Carlsbad, Calif., company said it will amend in the next few weeks the IND now active for the agent in other indications. ...